Marshall Wace’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.02M Sell
146,904
-184,726
-56% -$2.78M ﹤0.01% 1778
2025
Q4
$5.98M Sell
331,630
-746,208
-69% -$13.4M 0.01% 1074
2025
Q3
$20M Buy
1,077,838
+798,337
+286% +$12.5M 0.02% 654
2025
Q2
$4.47M Buy
+279,501
New +$4.98M 0.01% 1195
2024
Q4
Sell
-26,548
Closed -$447K 2622
2024
Q3
$447K Sell
26,548
-955,500
-97% -$14.2M ﹤0.01% 1960
2024
Q2
$11.7M Sell
982,048
-253,095
-20% -$2.83M 0.02% 664
2024
Q1
$13.7M Buy
1,235,143
+336,286
+37% +$3.43M 0.02% 640
2023
Q4
$7.78M Buy
898,857
+401,454
+81% +$3.12M 0.01% 757
2023
Q3
$3.81M Buy
497,403
+458,889
+1,191% +$3.44M 0.01% 974
2023
Q2
$277K Buy
+38,514
New +$225K ﹤0.01% 2163

Other funds holding CLBT